DK3484457T3 - Topisk formulering til fremme af sårheling - Google Patents
Topisk formulering til fremme af sårheling Download PDFInfo
- Publication number
- DK3484457T3 DK3484457T3 DK17830439.0T DK17830439T DK3484457T3 DK 3484457 T3 DK3484457 T3 DK 3484457T3 DK 17830439 T DK17830439 T DK 17830439T DK 3484457 T3 DK3484457 T3 DK 3484457T3
- Authority
- DK
- Denmark
- Prior art keywords
- wound healing
- topical formulation
- promote wound
- promote
- topical
- Prior art date
Links
- 239000012049 topical pharmaceutical composition Substances 0.000 title 1
- 230000029663 wound healing Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Dermatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662363284P | 2016-07-17 | 2016-07-17 | |
| PCT/CN2017/093118 WO2018014805A1 (en) | 2016-07-17 | 2017-07-17 | Topical formulation for promoting wound healing |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3484457T3 true DK3484457T3 (da) | 2023-07-10 |
Family
ID=60942314
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK17830439.0T DK3484457T3 (da) | 2016-07-17 | 2017-07-17 | Topisk formulering til fremme af sårheling |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US10758584B2 (da) |
| EP (1) | EP3484457B1 (da) |
| JP (2) | JP7538599B2 (da) |
| KR (1) | KR102362362B1 (da) |
| CN (1) | CN108778262A (da) |
| CA (1) | CA3030774A1 (da) |
| DK (1) | DK3484457T3 (da) |
| ES (1) | ES2955844T3 (da) |
| FI (1) | FI3484457T3 (da) |
| HR (1) | HRP20230726T1 (da) |
| HU (1) | HUE062184T2 (da) |
| LT (1) | LT3484457T (da) |
| MX (1) | MX2019000769A (da) |
| MY (1) | MY193312A (da) |
| PH (1) | PH12019500126A1 (da) |
| PL (1) | PL3484457T3 (da) |
| PT (1) | PT3484457T (da) |
| RS (1) | RS64356B1 (da) |
| RU (1) | RU2750286C2 (da) |
| SA (1) | SA519400913B1 (da) |
| SG (1) | SG11201900408RA (da) |
| SI (1) | SI3484457T1 (da) |
| TW (1) | TWI746597B (da) |
| WO (1) | WO2018014805A1 (da) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7172438B2 (ja) * | 2018-10-24 | 2022-11-16 | ライオン株式会社 | 水性眼科用組成物及び保存効力向上方法 |
| CN111297877A (zh) * | 2019-12-31 | 2020-06-19 | 中国药科大学 | 积雪草苷或其类似物的制药用途 |
| KR102583283B1 (ko) * | 2021-04-15 | 2023-09-27 | 주식회사 엘지생활건강 | 고함량의 센텔라아시아티카 정량추출물을 포함하는 안정한 화장료 조성물 |
| CN113209007B (zh) * | 2021-05-17 | 2022-11-25 | 海南普利制药股份有限公司 | 积雪苷外用制剂及其制备方法 |
| WO2023274123A1 (en) * | 2021-06-28 | 2023-01-05 | Oneness Biotech Co., Ltd. | Methods for preparation of plectranthus amboinicus extracts |
| WO2023227087A1 (en) * | 2022-05-27 | 2023-11-30 | Oneness Biotech Co., Ltd. | Plectranthus amboinicus extract for use in inhibiting immune responses |
| US20230414558A1 (en) * | 2022-06-27 | 2023-12-28 | Oneness Biotech Co., Ltd. | Plectranthus amboinicus extract for use in alleviation of radiation-induced skin disorders |
| WO2024159451A1 (en) * | 2023-02-01 | 2024-08-08 | Oneness Biotech Co., Ltd. | Plectranthus amboinicus extract for use in scar cosmesis |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2459661A1 (fr) | 1979-06-25 | 1981-01-16 | Phybiocit Laboratoires | Nouvelle composition medicamenteuse a base de plantes, et procede de preparation |
| CN1049122C (zh) | 1993-01-11 | 2000-02-09 | 李厚清 | 复方外伤软膏 |
| CN1067976C (zh) | 1994-12-03 | 2001-07-04 | 东国制药株式会社 | 积雪草酸衍生物及其制备方法和包含该衍生物的皮科制剂 |
| TW299064U (en) | 1995-01-23 | 1997-02-21 | Hitachi Ltd | Resin molded transformer |
| US6267996B1 (en) | 1996-10-17 | 2001-07-31 | Indena S.P.A | Pharmaceutical and cosmetic formulations with antimicrobial activity |
| KR100228873B1 (ko) | 1997-03-24 | 1999-11-01 | 강재헌 | 센텔라아시아티카에서 분리한 아시아티코사이드와 마테카소 사이드의 수용성 추출물을 함유한 간세포 및 항간섬유화 치료제 |
| CN1194154A (zh) | 1997-03-24 | 1998-09-30 | 东国制药株式会社 | 自积雪草的积雪草苷和羟基的积雪草苷和羧基积雪草苷的水溶性提取物及其分离方法 |
| EP1242103B1 (en) * | 1999-08-27 | 2009-01-07 | CJ Cheiljedang Corp. | Extracts derived from pueraria mirifica and extraction thereof |
| CN1137681C (zh) | 2000-11-21 | 2004-02-11 | 国家医药管理局上海医药工业研究院 | 积雪甙防粘膜及制备方法 |
| CN1127970C (zh) | 2001-03-14 | 2003-11-19 | 周华国 | 一种治疗烧伤的药膏及其制备方法 |
| US6579543B1 (en) | 2002-02-22 | 2003-06-17 | Jackie H. McClung | Composition for topical application to skin |
| JP2004059482A (ja) | 2002-07-29 | 2004-02-26 | Masahiro Sakanaka | 組織再生促進剤 |
| US20060099283A1 (en) | 2004-11-10 | 2006-05-11 | We Gene Technologies, Inc. | Leaf juice of plectranthus amboinicus for treating cancer and/or tumor |
| CN1682744A (zh) | 2005-03-15 | 2005-10-19 | 天津大学 | 制备积雪草苷巴布剂的方法 |
| TWI361074B (en) | 2005-12-22 | 2012-04-01 | Dev Center Biotechnology | Plant extracts for enhancing healing of wounds,and the preparation process and use thereof |
| TWI320714B (en) | 2006-09-15 | 2010-02-21 | Dev Center Biotechnology | Plant extracts for the treatment of rheumatoid arthritis |
| EP1925310B1 (en) * | 2006-11-24 | 2015-03-25 | Development Center For Biotechnology | Plant extracts from Plectranthus and Centella for treating skin disorders and accelerating wound healing in diabetic patients |
| CA2677872C (en) * | 2007-02-12 | 2012-04-03 | Indus Biotech Private Limited | A composition for selective serotonin reuptake inhibition and process thereof |
| US8449924B2 (en) * | 2007-08-29 | 2013-05-28 | Development Center For Biotechnology | Process for the preparation of plant extracts for treating skin disorders and enhancing healing of wounds |
| JP4853442B2 (ja) | 2007-09-27 | 2012-01-11 | パナソニック株式会社 | ミストサウナ装置 |
| WO2011103449A2 (en) * | 2010-02-19 | 2011-08-25 | Mary Kay Inc. | Topical skin care formulation |
| KR101632369B1 (ko) * | 2010-06-10 | 2016-06-21 | 인두스 바이오텍 프라이빗 리미티드 | 센텔라 아시아티카로부터 고순도 아시아티코사이드 조성물의 제조 방법 및 그 사용 방법 |
| FR2964570A1 (fr) | 2010-09-09 | 2012-03-16 | Burgundy | Procede de preparation d'un extrait de centella asiatica |
| TWI501772B (zh) * | 2011-11-22 | 2015-10-01 | Oneness Biotech Co | 具抗關節炎活性的到手香精萃物 |
| CN103420967A (zh) | 2013-08-19 | 2013-12-04 | 南京标科生物科技有限公司 | 一种滨蓟黄素的制备方法 |
| TWI663982B (zh) * | 2013-09-03 | 2019-07-01 | 合一生技股份有限公司 | 到手香萃取物用於製備具抗微生物功效組合物之用途 |
| CN107072979B (zh) | 2014-09-05 | 2021-05-18 | 合一生技股份有限公司 | 类黄酮化合物在制备伤口愈合组合物的用途 |
-
2017
- 2017-07-17 KR KR1020197004556A patent/KR102362362B1/ko active IP Right Grant
- 2017-07-17 SI SI201731369T patent/SI3484457T1/sl unknown
- 2017-07-17 CN CN201780009172.7A patent/CN108778262A/zh active Pending
- 2017-07-17 LT LTEPPCT/CN2017/093118T patent/LT3484457T/lt unknown
- 2017-07-17 WO PCT/CN2017/093118 patent/WO2018014805A1/en unknown
- 2017-07-17 DK DK17830439.0T patent/DK3484457T3/da active
- 2017-07-17 RS RS20230554A patent/RS64356B1/sr unknown
- 2017-07-17 PL PL17830439.0T patent/PL3484457T3/pl unknown
- 2017-07-17 TW TW106123820A patent/TWI746597B/zh active
- 2017-07-17 US US15/651,337 patent/US10758584B2/en active Active
- 2017-07-17 MX MX2019000769A patent/MX2019000769A/es unknown
- 2017-07-17 MY MYPI2019000107A patent/MY193312A/en unknown
- 2017-07-17 CA CA3030774A patent/CA3030774A1/en active Pending
- 2017-07-17 HU HUE17830439A patent/HUE062184T2/hu unknown
- 2017-07-17 SG SG11201900408RA patent/SG11201900408RA/en unknown
- 2017-07-17 ES ES17830439T patent/ES2955844T3/es active Active
- 2017-07-17 JP JP2019502066A patent/JP7538599B2/ja active Active
- 2017-07-17 HR HRP20230726TT patent/HRP20230726T1/hr unknown
- 2017-07-17 EP EP17830439.0A patent/EP3484457B1/en active Active
- 2017-07-17 RU RU2019104255A patent/RU2750286C2/ru active
- 2017-07-17 FI FIEP17830439.0T patent/FI3484457T3/fi active
- 2017-07-17 PT PT178304390T patent/PT3484457T/pt unknown
-
2019
- 2019-01-15 SA SA519400913A patent/SA519400913B1/ar unknown
- 2019-01-17 PH PH12019500126A patent/PH12019500126A1/en unknown
-
2022
- 2022-08-04 JP JP2022124798A patent/JP7469400B2/ja active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3484457T3 (da) | Topisk formulering til fremme af sårheling | |
| DK3120831T3 (da) | Topikal levering af hudsammensætninger med lav ph | |
| DK3328414T3 (da) | Sammensætning til anvendelse i fremme af sårheling | |
| DK3261721T3 (da) | Anvendelse af pridopidin til forbedring af hukommelse | |
| CL2016001645A1 (es) | Dispositivo domestico para preparar agua-soda | |
| BR112016021011A2 (pt) | composição tópica e usos de um composto | |
| BR302013004392S1 (pt) | Configuração aplicada emmetal sanitário | |
| DK2968214T3 (da) | Hidtil ukendte analgetiske sammensætninger | |
| DK3473263T3 (da) | Kombinerede præparater til behandling af kræft | |
| DK3013544T3 (da) | Fremgangsmåde til betonfremstilling | |
| DK2777689T3 (da) | Ny farmaceutisk sammensætning til behandling af svampeinfektioner | |
| DK3052102T3 (da) | Sammensætninger til behandling af cancere | |
| DK2953621T3 (da) | Topisk antimykotisk sammensætning til behandling af onykomykose | |
| BR112016021875A2 (pt) | composição tópica | |
| DK3349752T3 (da) | Aza-adamantan sammensætning til sårheling | |
| DK3393517T3 (da) | Acetylsalicylsyre til anvendelse til behandling af moderat til alvorlig influenza | |
| DK3397619T3 (da) | Salve | |
| DK3405197T3 (da) | Topisk behandling af håndeksem | |
| MA44394A (fr) | Compositions antivirales topiques | |
| DK3131572T3 (da) | Apc-analog til anvendelse til sårheling | |
| MA43166A (fr) | Formulation de fviii | |
| DK3104839T3 (da) | Topiske formuleringer af heparin | |
| MA50241A (fr) | Formulations topiques de chloroprocaïne | |
| TR201512960A1 (tr) | Topi̇kal formülasyonlar | |
| DK3349722T3 (da) | Topisk hirsutisme-behandling |